Q3 2025 Harrow Inc Earnings Call Transcript

Nov 11, 2025 / 01:00 PM GMT

Release Date Price: €7.35

Transcript 10-Q8-K

Key Points

Positve

Harrow Inc (HROW) reported a 45% increase in total revenue for the third quarter compared to the same period in 2024, reaching $71.6 million.
The company is on track for a strong year of revenue growth, with a full-year revenue outlook updated to a range of $270 to $280 million.
Harrow Inc (HROW) has secured agreements with several leading national payers, which will improve coverage for its products starting January 2026.
The company is preparing for four new product launches over the next three years, which are expected to significantly expand its market reach.
Harrow Inc (HROW) has built a scalable commercial infrastructure that supports multiple product launches and continued expansion without heavy additional investment.

Negative

Triessence and the rare and specialty portfolio underperformed this year, including in the third quarter.
There is an ongoing dispute with the California Board of Pharmacy regarding the renewal of the Imprimus Rx license, which could impact future revenue.
The company experienced an inventory shortage in October, causing a one-time decrease of about $4 to $6 million in revenue for the fourth quarter.
Harrow Inc (HROW) has updated its full-year revenue guidance to a slightly more conservative range, indicating potential challenges in hitting the original target.
The company anticipates a typical seasonal decline from Q4 2025 to Q1 2026, which could impact short-term financial performance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HROW.OQ - Harrow Inc
Q3 2025 Harrow Inc Earnings Call
Nov 11, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Herald 3rd quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. Instructions will be given at that time. As a reminder, this call may be recorded. I would like to turn the call over to Mike Viega, Vice President of Investor Relations and communications. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good morning and welcome to Harrow's 3rd quarter 2025 earnings conference call. My name is Mike Viega, Vice President

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.